TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12681371

Group type: EXPERIMENTAL
Intervention: 0.23 mg/kg ketamine hydrochloride followed by 0.5 mg/kg ketamine over 45 min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 10964037

Group type: EXPERIMENTAL
Intervention: Strength measurement instrument using a strain gauge force transducer, bridge amplifier, and mechanical structure; assessed for reproducibility in ALS patients and normal subjects.
Number of subjects: 41

Group type: COMPARATOR
Intervention: Interexaminer reproducibility assessed in ALS patients and normal subjects.
Number of subjects: 41
Study: 9006256

Group type: EXPERIMENTAL
Intervention: Soft bedding (very soft mattress)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hard mattress
Number of subjects: 0
Study: 1320287

Group type: EXPERIMENTAL
Intervention: nedocromil sodium (4 mg q.i.d.)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: sodium cromoglycate (10 micrograms q.i.d.)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate (500 micrograms t.i.d.)
Number of subjects: 165
Study: 6095322

Group type: EXPERIMENTAL
Intervention: 40 mg ACTH 4‐9 analog, ORG 2766
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31533783

Group type: EXPERIMENTAL
Intervention: Low-intensity problem-solving intervention delivered over 3 weeks by lay counsellors
Number of subjects: 240

Group type: COMPARATOR
Intervention: Enhanced usual care comprised of problem-solving booklets
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Low-intensity problem-solving intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Classroom-based sensitization intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: School-level sensitization activities
Number of subjects: 240
Study: 29172596

Group type: EXPERIMENTAL
Intervention: HOPS intervention
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: CHIEF intervention
Number of subjects: 280
Study: 26053189

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (3‐min intervals at 40% and 80% VO2peak for 30 mins/day, 3 days/wk for 12 wks)
Number of subjects: 120
Study: 24299513

Group type: EXPERIMENTAL
Intervention: Larval therapy dressing (BioFOAM)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Hydrogel (Purilon gel)
Number of subjects: 88
Study: 22540269

Group type: EXPERIMENTAL
Intervention: Radiopaque ENG implant
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-radiopaque ENG implant
Number of subjects: 52
Study: 20189173

Group type: EXPERIMENTAL
Intervention: Ventrogluteal site
Number of subjects: 580

Group type: COMPARATOR
Intervention: Anterolateral thigh site
Number of subjects: 580
Study: 17510461

Group type: EXPERIMENTAL
Intervention: Transition from household ambulation to limited community ambulation (68% of 19 household ambulators)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Transition from limited community ambulation to full community ambulation (38% of 45 limited community ambulators)
Number of subjects: 64
Study: 16170947

Group type: EXPERIMENTAL
Intervention: Augmented force-feedback fields with gradual start and abrupt ending
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electromechanical force-feedback trackball (control device)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gender effect observed
Number of subjects: 0
Study: 12066212

Group type: EXPERIMENTAL
Intervention: Oral doxifluridine (5'‐DFUR)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Oral 5‐fluorouracil (5‐FU)
Number of subjects: 482
Study: 9891531

Group type: EXPERIMENTAL
Intervention: 5‐FU plus HCFU (group A)
Number of subjects: 251

Group type: COMPARATOR
Intervention: 5‐FU injections only (group B)
Number of subjects: 251
Study: 8069985

Group type: EXPERIMENTAL
Intervention: Pipecuronium 100 micrograms.kg‐1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pancuronium 150 micrograms.kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pipecuronium
Number of subjects: 30
Study: 2962837

Group type: EXPERIMENTAL
Intervention: Procaterol 0.1 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30840085

Group type: EXPERIMENTAL
Intervention: iPACT‐E‐Trauma (self‐management intervention)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Educational pamphlet (control)
Number of subjects: 56
Study: 30409195

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acupuncture (real and sham) with lifestyle interventions
Number of subjects: 10
Study: 26597414

Group type: EXPERIMENTAL
Intervention: Walk On! physical activity coaching intervention
Number of subjects: 1650

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1650
Study: 25129551

Group type: EXPERIMENTAL
Intervention: RCHT + EPO
Number of subjects: 385

Group type: COMPARATOR
Intervention: RCHT
Number of subjects: 385
Study: 22711428

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) 24 IU
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lorazepam (LZP) 2 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 45
Study: 20562609

Group type: EXPERIMENTAL
Intervention: Repeat Back (RB) method added to iMedConsent
Number of subjects: 575

Group type: COMPARATOR
Intervention: Standard iMedConsent (no RB)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Repeat Back (RB) method for carotid endarterectomy patients
Number of subjects: 575

Group type: COMPARATOR
Intervention: Standard iMedConsent (no RB) for carotid endarterectomy patients
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Repeat Back (RB) method
Number of subjects: 575
Study: 17605816

Group type: EXPERIMENTAL
Intervention: Expert panel assessment of paired images (better/worse decision)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Independent readers scoring using the van der Heijde-modified Sharp method
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Assessment of repair features by expert panel
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Change in size of erosion
Number of subjects: 64
Study: 16129086

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-protein diet
Number of subjects: 28

Group type: COMPARATOR
Intervention: High-carbohydrate/low-fat diet
Number of subjects: 28
Study: 12092746

Group type: EXPERIMENTAL
Intervention: Encapsulated enteric-coated beads (400 mg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Buffered tablet (400 mg)
Number of subjects: 76
Study: 10345908

Group type: EXPERIMENTAL
Intervention: Worksite Intervention
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: Worksite Plus Family Intervention
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Minimal Intervention
Number of subjects: 1359
Study: 8697497

Group type: EXPERIMENTAL
Intervention: Mid-laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microcurrent electrical stimulation (MENS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 2530020

Group type: EXPERIMENTAL
Intervention: Arterial ANF concentrations
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Venous ANF concentrations
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Extraction ratios for ANF
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Plasma ANF concentration in a peripheral arm vein
Number of subjects: 10
Study: 130574

Group type: EXPERIMENTAL
Intervention: 4% lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: saline
Number of subjects: 100
Study: 7010982

Group type: EXPERIMENTAL
Intervention: Dextrose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Potato
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rice
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Corn
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bread
Number of subjects: 20
Study: 31963598

Group type: EXPERIMENTAL
Intervention: Aislados intervention program (video game)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 187
Study: 31432220

Group type: EXPERIMENTAL
Intervention: FREEWAY™ drug‐eluting balloon
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard PTA balloon angioplasty
Number of subjects: 204
Study: 27344103

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring and imagery modification (CRIM-PTSD)
Number of subjects: 10
Study: 26038960

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 300 mg formulation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Isoniazid (INH) 100 mg formulation (reference product)
Number of subjects: 28
Study: 24588117

Group type: EXPERIMENTAL
Intervention: Asymptomatic HAE patients
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: During clinical attack
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: During next 24 hours of abdominal attack
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Post-attack levels in abdominal attack patients
Number of subjects: 68
Study: 22622364

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) using the Moja-De protocol
Number of subjects: 24

Group type: COMPARATOR
Intervention: TRP-balanced amino acid load (BAL)
Number of subjects: 24
Study: 19404717

Group type: EXPERIMENTAL
Intervention: Revised New Forest Parenting Programme (NFPP)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 41
Study: 17523968

Group type: EXPERIMENTAL
Intervention: Diabetes service model intervention in community pharmacies over 6 months
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Diabetes service model intervention in community pharmacies
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 289
Study: 15090169

Group type: EXPERIMENTAL
Intervention: Revised protocol stating confidentiality would be broken if a youth reported suicidal ideation
Number of subjects: 0
Study: 11279594

Group type: EXPERIMENTAL
Intervention: Memory assessment after 1 week for 6-month-olds
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Memory assessment after 1 week for 3-month-olds
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Increasing complexity of learned information
Number of subjects: 2
Study: 9730427

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 73

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Intravenous Tacrolimus
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Oral Tacrolimus
Number of subjects: 73
Study: 7995668

Group type: EXPERIMENTAL
Intervention: Communication processes related to alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social, situational, and individual factors related to alcohol
Number of subjects: 0
Study: 3292249

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (loading dose 20 mg/kg, maintenance dose 10 mg/kg per day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Caffeine citrate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29718460

Group type: EXPERIMENTAL
Intervention: Cigarettes with 2.4-0.4 mg/g nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cigarettes with usual-brand nicotine content
Number of subjects: 0
Study: 28538644

Group type: EXPERIMENTAL
Intervention: CD28 immunomodulator (AB103) at 0.5 mg/kg, n = 15
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo, n = 10
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Retrospective data set (all patients)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Retrospective data set (high disease severity, mSOFA > 3)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: NICCE success
Number of subjects: 198
Study: 25415414

Group type: EXPERIMENTAL
Intervention: 20-second roller massager application
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 60-second roller massager application
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control condition (participants sat quietly)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Roller massage (both conditions)
Number of subjects: 10
Study: 23438677

Group type: EXPERIMENTAL
Intervention: Spinal plus isoflurane anesthesia
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Spinal plus desflurane anesthesia
Number of subjects: 106

Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Spinal plus isoflurane anesthesia and spinal plus desflurane anesthesia
Number of subjects: 106
Study: 21809698

Group type: EXPERIMENTAL
Intervention: anvifen (aminophenylbutyric acid)
Number of subjects: 18

Group type: COMPARATOR
Intervention: phenibut tablets
Number of subjects: 18
Study: 19380382

Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 21
Study: 16409440

Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg once daily (qd)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study: 15700749

Group type: EXPERIMENTAL
Intervention: Hydroalcoholic extract of C. curvisepala Lind. (3 times daily for more than 4 months)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (3 times daily for more than 4 months)
Number of subjects: 92
Study: 10589324

Group type: EXPERIMENTAL
Intervention: Multicomponent educational intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Routine medical care (Control)
Number of subjects: 280
Study: 8914345

Group type: EXPERIMENTAL
Intervention: I.D. microtyping system (Diamed)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Biovue system (Ortho Diagnostics)
Number of subjects: 1000
Study: 1649718

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin treatment (36 units/kg intravenously three times a week for 6 months, then 18 units/kg three times a week for 6 months)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Desferrioxamine chelation therapy (30 mg/kg intravenously three times a week for 6 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 6404174

Group type: EXPERIMENTAL
Intervention: Adriamycin plus cisplatin
Number of subjects: 273

Group type: COMPARATOR
Intervention: cisplatin alone
Number of subjects: 273

Group type: COMPARATOR
Intervention: thiotepa plus methotrexate
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: cisplatin plus cyclophosphamide
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: cisplatin plus Adriamycin
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: cisplatin plus hexamethylmelamine
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: cisplatin plus thiotepa
Number of subjects: 273
Study: 30753996

Group type: EXPERIMENTAL
Intervention: Mothers' PTSD symptoms
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fathers' PTSD symptoms
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Parents' own PTSD symptoms
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Partners' PTSD symptoms
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Interparental conflict
Number of subjects: 150
Study: 30287602

Group type: EXPERIMENTAL
Intervention: Assertive case management intervention for up to 24 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fidelity of the case management intervention
Number of subjects: 0
Study: 27025164

Group type: EXPERIMENTAL
Intervention: Open masks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Closed masks
Number of subjects: 50
Study: 24149990

Group type: EXPERIMENTAL
Intervention: EMLA cream phonophoresis (2.5 % lidocaine, 2.5 % prilocaine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional ultrasound therapy
Number of subjects: 50
Study: 23180067

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 0
Study: 21073760

Group type: EXPERIMENTAL
Intervention: Neuro-Emotional Technique (NET)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 18674741

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg orally thrice a day for 3 months)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 15920180

Group type: EXPERIMENTAL
Intervention: remifentanil 3.0 microg/kg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: propofol/remifentanil
Number of subjects: 64

Group type: COMPARATOR
Intervention: propofol/succinylcholine
Number of subjects: 64
Study: 12876173

Group type: EXPERIMENTAL
Intervention: Nebuliser hood
Number of subjects: 14

Group type: COMPARATOR
Intervention: SVN plus mask
Number of subjects: 14
Study: 10383539

Group type: EXPERIMENTAL
Intervention: Pressurized aerosol 800 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aqueous pump spray 400 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Powder 800 microg
Number of subjects: 16
Study: 9345419

Group type: EXPERIMENTAL
Intervention: 9 MIU intramuscular recombinant interferon alpha‐2a (rIFNA) (Roferon‐A, Roche) (n = 12)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: rIFNA treatment
Number of subjects: 20
Study: 1867894

Group type: EXPERIMENTAL
Intervention: Training program emphasizing development of tactile skills using silicone breast models
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Experimental group training
Number of subjects: 89

Group type: COMPARATOR
Intervention: Subset of experimental and control physicians' medical records
Number of subjects: 89
Study: 6349262

Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Porcine insulin
Number of subjects: 0
Study: 30206708

Group type: EXPERIMENTAL
Intervention: Honey mouthwash
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study: 28246067

Group type: EXPERIMENTAL
Intervention: Web-based direct recruitment approach (patient-centric, PC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Center of excellence (CoE) recruitment
Number of subjects: 64
Study: 26314746

Group type: EXPERIMENTAL
Intervention: Real-time knowledge of performance (KP) feedback
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Rhythmic cueing in the form of knowledge of results (KR) feedback
Number of subjects: 5

Group type: COMPARATOR
Intervention: No feedback (control)
Number of subjects: 5
Study: 24717258

Group type: EXPERIMENTAL
Intervention: VPA + memantine (5 mg/d)
Number of subjects: 214

Group type: COMPARATOR
Intervention: VPA + placebo
Number of subjects: 214
Study: 22197753

Group type: EXPERIMENTAL
Intervention: Sensory interference task
Number of subjects: 105

Group type: COMPARATOR
Intervention: No interference task
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conceptual interference task
Number of subjects: 105
Study: 20598142

Group type: EXPERIMENTAL
Intervention: Single dose of three medium hardboiled eggs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Daily consumption of egg substitute for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sausage/cheese breakfast sandwich
Number of subjects: 40
Study: 19034103

Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 microg/kg)
Number of subjects: 2488

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2488
Study: 15910128

Group type: EXPERIMENTAL
Intervention: Visuospatial order reconstruction task with varying path characteristics (path crossing, path length, angles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visuospatial order reconstruction task
Number of subjects: 0
Study: 12454298

Group type: EXPERIMENTAL
Intervention: High dose prednisolone and continuous nebulised salbutamol (US regimen)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Lower dose prednisolone and bolus nebulised salbutamol (UK regimen)
Number of subjects: 170
Study: 10511066

Group type: EXPERIMENTAL
Intervention: Ascending dosing pattern of methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twice-daily dosing pattern of methylphenidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flat dosing pattern of methylphenidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-times-a-day regimens of methylphenidate
Number of subjects: 0
Study: 8476617

Group type: EXPERIMENTAL
Intervention: 40 ml of 0.25% bupivacaine with epinephrine (0.5 mg per 100 ml of solution)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 ml of 0.5% bupivacaine with epinephrine (0.5 mg per 100 ml of solution)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both groups (40 ml of 0.25% bupivacaine and 20 ml of 0.5% bupivacaine)
Number of subjects: 18
Study: 3540875

Group type: EXPERIMENTAL
Intervention: Aspirin-caffeine-codeine-butalbital combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen-codeine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30337315

Group type: EXPERIMENTAL
Intervention: Aussie-FIT intervention (12 weekly 90 min workshops)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist comparison group
Number of subjects: 120
Study: 27711094

Group type: EXPERIMENTAL
Intervention: URS
Number of subjects: 65

Group type: COMPARATOR
Intervention: SWL
Number of subjects: 65
Study: 26081224

Group type: EXPERIMENTAL
Intervention: Dietary fish (canned salmon + albacore)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: n-3 PUFA capsules
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups (Dietary fish and n-3 PUFA capsules)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fish arm
Number of subjects: 25
Study: 24194642

Group type: EXPERIMENTAL
Intervention: Risperidone long-acting injection (LAI) plus COMPASS (COMprehensive Psycho‐educational Approach and Scheme Set)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Risperidone long-acting injection (LAI) alone (control group)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Risperidone LAI plus COMPASS
Number of subjects: 96
Study: 21448219

Group type: EXPERIMENTAL
Intervention: Probiotic milk drink (Yacult) consumed daily for 28 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no probiotic food or drink)
Number of subjects: 28